XML 48 R29.htm IDEA: XBRL DOCUMENT

Subsequent Events	3 Months Ended
Subsequent Events	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Sale of Priority Review Voucher On April 24, 2024, we entered into a definitive agreement with a third party to sell a rare pediatric disease priority review voucher. In consideration for the PRV we received $103.0 million upon the closing of the PRV purchase.